192 related articles for article (PubMed ID: 34442003)
1. Efficacy of Sirolimus Treatment in PEComa-10 Years of Practice Perspective.
Świtaj T; Sobiborowicz A; Teterycz P; Klimczak A; Makuła D; Wągrodzki M; Szumera-Ciećkiewicz A; Rutkowski P; Czarnecka AM
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442003
[TBL] [Abstract][Full Text] [Related]
2. Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors.
Sanfilippo R; Fabbroni C; Fucà G; Fumagalli E; Morosi C; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2020 Oct; 26(20):5534-5538. PubMed ID: 32605908
[TBL] [Abstract][Full Text] [Related]
3. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.
Meredith L; Chao T; Nevler A; Basu Mallick A; Singla RK; McCue PA; Bowne WB; Jiang W
Diagn Pathol; 2023 Apr; 18(1):45. PubMed ID: 37041531
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Long-Term Efficacy of PEComa Treatment-20 Years of Experience.
Sobiborowicz A; Świtaj T; Teterycz P; Spałek MJ; Szumera-Ciećkiewicz A; Wągrodzki M; Zdzienicki M; Czarnecka AM; Rutkowski P
J Clin Med; 2021 May; 10(10):. PubMed ID: 34069629
[TBL] [Abstract][Full Text] [Related]
5. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
Testa S; Bui NQ; Ganjoo KN
Cancer Res Commun; 2023 Jul; 3(7):1212-1223. PubMed ID: 37448552
[TBL] [Abstract][Full Text] [Related]
6.
Wagner AJ; Ravi V; Riedel RF; Ganjoo K; Van Tine BA; Chugh R; Cranmer L; Gordon EM; Hornick JL; Du H; Grigorian B; Schmid AN; Hou S; Harris K; Kwiatkowski DJ; Desai NP; Dickson MA
J Clin Oncol; 2021 Nov; 39(33):3660-3670. PubMed ID: 34637337
[TBL] [Abstract][Full Text] [Related]
7. Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).
Sanfilippo R; Jones RL; Blay JY; Le Cesne A; Provenzano S; Antoniou G; Mir O; Fucà G; Fumagalli E; Bertulli R; Stacchiotti S; Brahmi M; Grosso F; Dufresne A; Hindi N; Sbaraglia M; Gronchi A; Collini P; Dei Tos AP; Casali PG
Clin Cancer Res; 2019 Sep; 25(17):5295-5300. PubMed ID: 31217199
[TBL] [Abstract][Full Text] [Related]
8. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
9. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
Vang R; Kempson RL
Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764
[TBL] [Abstract][Full Text] [Related]
10. Primary perivascular epithelioid cell tumor (PEComa) in bone: A review of the literature and a case arising in the humerus with multiple metastases.
Zhong J; Hu Y; Si L; Xing Y; Geng J; Jiao Q; Zhang H; Yao W
J Bone Oncol; 2021 Feb; 26():100336. PubMed ID: 33240785
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
Bergamo F; Maruzzo M; Basso U; Montesco MC; Zagonel V; Gringeri E; Cillo U
World J Surg Oncol; 2014 Feb; 12():46. PubMed ID: 24575738
[TBL] [Abstract][Full Text] [Related]
12. Phase II Trial of
Wagner AJ; Ravi V; Riedel RF; Ganjoo K; Van Tine BA; Chugh R; Cranmer L; Gordon EM; Hornick JL; Du H; Ding L; Schmid AN; Navarro WH; Kwiatkowski DJ; Dickson MA
J Clin Oncol; 2024 May; 42(13):1472-1476. PubMed ID: 38427923
[No Abstract] [Full Text] [Related]
13. Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor: a case report and literature review.
Raimondi A; Colombo F; Pintarelli G; Morosi C; Renne SL; Frezza AM; Saponara M; Dei Tos AP; Mazzocchi A; Provenzano S; Casali PG; Stacchiotti S
Anticancer Drugs; 2018 Jul; 29(6):589-595. PubMed ID: 29668485
[TBL] [Abstract][Full Text] [Related]
14. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract][Full Text] [Related]
15. First pancreatic perivascular epithelioid cell tumor (PEComa) treated by mTOR inhibitor.
Gondran H; Thebaud E; Moreau A; Le Rhun M; Touchefeu Y; Regenet N; Musquer N
Pancreatology; 2019 Jun; 19(4):566-568. PubMed ID: 31130397
[TBL] [Abstract][Full Text] [Related]
16. Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network.
Stacchiotti S; Simeone N; Lo Vullo S; Baldi GG; Brunello A; Vincenzi B; Palassini E; Dagrada G; Collini P; Morosi C; Greco FG; Sbaraglia M; Dei Tos AP; Mariani L; Frezza AM; Casali PG
Cancer; 2021 Feb; 127(4):569-576. PubMed ID: 33107985
[TBL] [Abstract][Full Text] [Related]
17. The role of (18)F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor.
Sun L; Sun X; Li Y; Xing L
Onco Targets Ther; 2015; 8():1967-70. PubMed ID: 26257526
[TBL] [Abstract][Full Text] [Related]
18. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports].
El Gani-Mesrar M; Bonneau C; Michenet P; Gourvennec JB; Tabareau-Delalande F
Ann Pathol; 2021 Feb; 41(1):118-122. PubMed ID: 32646778
[TBL] [Abstract][Full Text] [Related]
19. Rapidly enlarging malignant abdominal PEComa with hepatic metastasis: a promising initial response to sirolimus following surgical excision of primary tumor.
Uhlenhopp DJ; West J; Heckart J; Campbell R; Elhaddad A
Oxf Med Case Reports; 2020 Mar; 2020(3):omaa013. PubMed ID: 32257249
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic radical nephroureterectomy in the oblique supine lithotomy integrative position for rare renal malignant perivascular epithelioid cell tumor with renal vein cancerous thrombosis: A case report and literature review.
Lin C; Liang S; Wang Y; Liang A; Qin W; Huang J; Meng H; Liu H; Chen M; Meng L
Medicine (Baltimore); 2022 Sep; 101(38):e30653. PubMed ID: 36197208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
